We, therefore, assume that the FAK/RhoA regulatory network may be important in other SMG-induced physiological alterations, such as SMG-induced bone loss [49], often seen in rheumatoid arthritis [50]. The gene discussed is PTK2; the disease is rheumatoid arthritis.